Immunosuppressory mini-regions of HLA-DP and HLA-DR

Molecular Immunology

Volumn 36, Issue 8, 1999, Pages 525-533

  Szewczuk, Zbigniew ^a   Wilczyński, Andrzej ^a   Stefanowicz, Piotr ^a   Fedorowicz, Wioletta ^a   Siemion, Ignacy Z ^a   Wieczorek, Zbigniew ^b  

^a UNIVERSITY OF WROC AW   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

CD4; Histocompatibility antigen; HLA DP; HLA DQ; HLA DR; Immunosuppressors; MHC proteins; RGD Sequence; Thymopentin analogs

Indexed keywords

HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CELLULAR IMMUNITY; CIRCULAR DICHROISM; CRYSTAL STRUCTURE; GENE LOCUS; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; CIRCULAR DICHROISM; HEMOLYTIC PLAQUE TECHNIQUE; HLA-DP ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED CBA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

RICE GALL DWARF VIRUS;

EID: 0344563486     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00066-8     Document Type: Article

References (27)

1. Brogdon J., Eckels D.D., Davies C., White S., Doyle C. A site for CD4 binding in the β1 domain of the MHC class II protein HLA-DR1. J. Immunol. 161:1998;5472-5480.
2. Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. 3-Dimensional structure of the human class-II histocompatibility antigen HLA-DR1. Nature. 364:1993;33-39.
3. Cammarota G., Scheirle A., Takacs B., Doran D.M., Knorr R., Bannwarth W., Guardiola J., Sinigaglia F. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature. 356:1992;799-801.
4. Campbell R.D., Trowsdale J. Map of human MHC. Immunol. Today. 14:1993;349-352.
5. Cebrat M., Wieczorek Z., Siemion I.Z. Immunosuppressive activity of hymenistatin I. Peptides. 17:1996;191-196.
6. Fleury S., Thibodeau J., Croteau G., Labrecque N., Aronson H.E., Cantin C., Long E.O., Sekaly R.P. HLA-DR polymorphism affects the interaction with CD4. J. Exp. Med. 182:1995;733-741.
7. Gorga J.C. Structural analysis of class II major histocompatibility complex proteins. Crit. Rev. Immunol. 11:1992;305-335.
8. Lagrange P.H., Macksaness G.B., Miller T.E., Pardon P. Influence of dose and route of antigen injection on the immunological induction of T cells. J. Exp. Med. 139:1974;528-542.
9. Lamthanh H., Roumestand C., Deprun C., Menez A. Side reaction during the deprotection of (S-acetamidomethyl)cysteine in a peptide with a high serine and threonine content. Int. J. Peptide Protein Res. 41:1993;85-95.
10. Lotteau V., Teyton R., Borroughs D., Charron D. A novel HLA class II molecule (DRαDQβ) created by mismatched isotope pairing. Nature. 329:1987;339-342.
11. Mishell R.I., Dutton R.W. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126:1967;423-428.
12. Nydam T., Wade T.K., Yadati S., Gabriel J.L., Barisas B.G., Wade W.F. Mutations in MHC class II dimer of dimers contact residues: effects on antigen presentation. Int. Immunol. 10:1998;1237-1249.
13. Paliakasis K., Routsias J., Petratos K., Ouzounis C., Kokkinidis M., Papadopoulos G.K. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR. J. Struct. Biol. 117:1996;145-163.
14. Perczel A., Fasman G.D. Quantitative analysis of cyclic β-turn models. Protein Sci. 1:1992;378-395.
15. Perczel A., Hollosi M., Sandor P., Fasman G.D. The evaluation of type I and type II beta-turn mixtures. Circular dichroism, NMR and molecular dynamics studies. Int. J. Peptide Protein Res. 41:1993;223-236.
16. Sakihama T., Smolyar A., Reinherz E.L. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natn. Acad. Sci. USA. 92:1995;6444-6448.
17. Satoh T., Aramini J.M., Li S., Friedman T.M., Gao J., Edling A.E., Townsend R., Koch U., Choksi S., Germann M.W., Korngold R., Huang Z. Bioactive peptide design based on protein surface epitopes. A cyclic heptapeptide mimics CD4 domain 1 CC′ loop and inhibits CD4 biological function. J. Biol. Chem. 272:1997;12,175-12,180.
18. Schafer P.H., Pierce S.K., Jardetzky T.S. The structure of MHC class II: a role for dimer of dimers. Semin. Immunol. 7:1995;389-398.
19. Schafer P.H., Malapati S., Hanfelt K.K., Pierce S.K. The assembly and stability of MHC class II-(alpha beta)2 superdimers. J. Immunol. 161:1998;2307-2316.
20. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., Wiley D.C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:1994;215-221.
21. Szewczuk Z., Siemion I.Z., Wieczorek Z. Immunological properties of the thymopentin-like fragments of HLA-DQ. Molec. Immunol. 33:1996;903-908.
22. Szewczuk Z., Stefanowicz P., Wilczyński A., Siemion I.Z., Cierniewski C.S., Kralisz U., Wieczorek Z. The Immunosuppressory and adhesive mini-region of the human major histocompatibility protein, HLA-DQ. Biopolymers. 40:1996;571-583.
23. Szewczuk Z., Wieczorek Z., Stefanowicz P., Wilczyński A., Siemion I.Z. Further investigations on thymopentin-like fragments of HLA-DQ and their analogues. Arch. Immunol. Exp. Ther. 45:1997;335-341.
24. Weber S., Karjalainen K. Mouse CD4 binds MHC class II with extremely low affinity. Int. Immunol. 5:1993;695-698.
25. Wieczorek Z., Voelter W., Nawrocka-Bolewska E., Zimecki M., Siemion I.Z. The unusually high immunomodulatory activity of thymopentin analogue Pro5-TP-5. Molec. Immunol. 28:1991;95-98.
26. Woody R.W. Circular dichroism in peptides. Hruby V.J. Peptides. vol. 7:1985;15-114 Academic Press, NY.
27. Zagury J.F., Bernard J., Achour A., Astgen A., Lachgar A., Fall L., Carelli C., Issing W., Mbika J.P., Picard O., Carlotti M., Callebaut I., Mornon J.P., Burny A., Feldman M., Bizzini B., Zagury D. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Proc. Natn. Acad. Sci. USA. 90:1993;7573-7577.